MPJE Prescription Dispensing Requirements 5

Question 1

Under the Poison Prevention Packaging Act (PPPA), which of the following is exempt from child-resistant container requirements?

Accepted Answer

Both A and B

Answer

Both sublingual nitroglycerin and oral contraceptives in unit-dose packaging are exempt from PPPA child-resistant container requirements.

Question 2

A patient who is hard of hearing requests large-print labels on all prescriptions. Under HIPAA and pharmacy law, how should the pharmacist respond?

Accepted Answer

The pharmacist should accommodate the request as part of effective communication requirements under the ADA

Answer

The Americans with Disabilities Act (ADA) requires pharmacies to provide effective communication, which includes accommodations such as large-print labels for patients with visual or hearing impairments.

Question 3

A pharmacy technician presents a completed prescription bag to a pharmacist for final verification. The pharmacist notices the NDC on the vial does not match the prescription. This is an example of which type of error prevention step?

Accepted Answer

Final pharmacist verification (drug utilization review)

Answer

The pharmacist's final check before dispensing, including verifying NDC against the prescription, is the final pharmacist verification step that catches preparation errors.

Question 4

A prescriber writes a prescription for 'Zolpidem CR 12.5 mg – dispense #30, 3 refills.' Zolpidem is a Schedule IV controlled substance. Under federal law, what is the maximum number of refills permitted?

Accepted Answer

5 refills within 6 months of the original prescription date

Answer

Federal law limits Schedule III–V prescriptions to a maximum of 5 refills within 6 months of the date issued, so the prescriber's 3 refills are within the allowable maximum.

Question 5

Which of the following best describes a pharmacist's 'corresponding responsibility' for controlled substance prescriptions?

Accepted Answer

The pharmacist shares legal responsibility with the prescriber for ensuring a controlled substance prescription is issued for a legitimate medical purpose

Answer

Under 21 CFR 1306.04, both the prescriber and the pharmacist share corresponding responsibility for ensuring a controlled substance prescription serves a legitimate medical purpose.

MPJE - Multistate Pharmacy Jurisprudence Examination Practice Test

MPJE - Multistate Pharmacy Jurisprudence Examination Practice Test

MPJE Prescription Dispensing Requirements 5